The effect of quinagolide and cabergoline, two selective dopamine receptor type 2 agonists, in the treatment of prolactinomas
2000 ◽
Vol 53
(1)
◽
pp. 53-60
◽
Keyword(s):
2017 ◽
Vol 140
(8)
◽
pp. 1870-1880
◽
Keyword(s):
Keyword(s):
Keyword(s):
Keyword(s):
2019 ◽
Vol 11
(1)
◽
pp. 3-13
◽
Keyword(s):